Manulife (Manufacturers Life Insurance)’s Immunic IMUX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-1,003
Closed -$96 3125
2021
Q4
$96 Buy
+1,003
New +$90.3K ﹤0.01% 3057
2019
Q1
Sell
-84
Closed -$6K 2630
2018
Q4
$6K Sell
84
-99
-54% -$11.6K ﹤0.01% 2514
2018
Q3
$20K Buy
183
+116
+173% +$303K ﹤0.01% 2918
2018
Q2
$183K Buy
67
+63
+1,575% +$146K ﹤0.01% 3189
2018
Q1
$10K Hold
4
﹤0.01% 3912
2017
Q4
$11K Buy
4
+3
+300% +$6.63K ﹤0.01% 3945
2017
Q3
$2K Sell
1
-1
-50% -$1.3K ﹤0.01% 4116
2017
Q2
$3K Sell
2
-31
-94% -$41.4K ﹤0.01% 4046
2017
Q1
$52K Buy
33
+20
+154% +$36.6K ﹤0.01% 3342
2016
Q4
$23K Sell
13
-33
-72% -$72.3K ﹤0.01% 3591
2016
Q3
$113K Hold
46
﹤0.01% 3154
2016
Q2
$114K Buy
46
+10
+28% +$32.9K ﹤0.01% 3160
2016
Q1
$131K Buy
36
+27
+300% +$93.8K ﹤0.01% 2898
2015
Q4
$41 Hold
9
﹤0.01% 3302
2015
Q3
$14 Sell
9
-20
-69% -$100K ﹤0.01% 3503
2015
Q2
$241 Buy
29
+17
+142% +$162K ﹤0.01% 2708
2015
Q1
$117 Buy
12
+4
+50% +$36.8K ﹤0.01% 3099
2014
Q4
$75 Sell
8
-1
-11% -$7.7K ﹤0.01% 3147
2014
Q3
$71 Buy
+9
New +$85K ﹤0.01% 3210
2014
Q2
Hold
0
3630

Other funds holding IMUX

Manulife (Manufacturers Life Insurance)'s IMUX Position: Q1 2022 in Review

Manulife (Manufacturers Life Insurance) sold out of Immunic (IMUX) in Q1 2022, closing a stake of 1,003 shares — an estimated $96 sold.

Manulife (Manufacturers Life Insurance) first reported a position in IMUX in Q3 2014 and held it in 19 quarters. The position peaked at $183K in Q2 2018. 80 funds tracked by Wall St. Rank hold IMUX as of Q1 2022.

  • Manulife (Manufacturers Life Insurance) reported no remaining Immunic position as of Q1 2022 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 1,003 Immunic shares in Q1 2022, an estimated $96.
  • Manulife (Manufacturers Life Insurance) first reported a position in Immunic in Q3 2014 and held it in 19 quarters.
  • Manulife (Manufacturers Life Insurance)'s Immunic position peaked at $183K in Q2 2018.
  • 80 funds tracked by Wall St. Rank held Immunic as of Q1 2022.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2022, filed 20 May 2022.